Endeavour Vision is a leading venture capital and growth equity firm investing in commercial-stage medtech and digital health companies. We invest in transformative healthcare technologies that provide superior clinical benefits for patients or bring significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018) and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s international investment teams are located in Geneva, Switzerland and Minneapolis, US.